4.7 Article

Congenital Human Cytomegalovirus Infection Is Associated With Decreased Transplacental IgG Transfer Efficiency Due to Maternal Hypergammaglobulinemia

期刊

CLINICAL INFECTIOUS DISEASES
卷 74, 期 7, 页码 1131-1140

出版社

OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciab627

关键词

congenital CMV infection; human cytomegalovirus; maternal hypergammaglobulinemia; maternal-fetal vaccination; transplacental IgG transfer

资金

  1. National Institutes of Health National Cancer Institute [1R21CA242439-01]
  2. National Institutes of Health National Institute of Allery and Infectious Diseases [1R21-AI147992]
  3. Duke University School of Medicine through Translating Duke Health's Children's Health and Discovery Initiative
  4. Duke University School of Medicine through Medearis CMV Scholars Program
  5. National Center For Advancing Translational Sciences of the National Institutes of Health [UL1TR002553]
  6. Duke CTSA [UL1TR002553, 05/02/184/30/23]
  7. BERD Methods Core [UL1TR002553, 05/02/184/30/23]

向作者/读者索取更多资源

The study found that congenital HCMV infection moderately reduces transplacental IgG transfer efficiency due to maternal hypergammaglobulinemia; however, infants with and without cCMV infection had similar antigen-specific IgG levels acquired from maternal IgG via transplacental transfer.
We evaluated transplacental IgG transfer in a case-control cohort of mother-infant pairs with and without congenital human cytomegalovirus (cCMV) infection. Transplacental immunoglobulin G (IgG) transfer efficiency was reduced in pairs with cCMV infection, primarily attributable to maternal hypergammaglobulinemia in HCMV-transmitting mothers. Background Placentally transferred maternal immunoglobulin G (IgG) protects against pathogens in early life, yet vertically transmitted infections can interfere with transplacental IgG transfer. Although human cytomegalovirus (HCMV) is the most common placentally-transmitted viral infection worldwide, the impact of congenital HCMV (cCMV) infection on transplacental IgG transfer has been underexplored. Methods We evaluated total and antigen-specific maternal and cord blood IgG levels and transplacental IgG transfer efficiency in a US-based cohort of 93 mother-infant pairs including 27 cCMV-infected and 66 cCMV-uninfected pairs, of which 29 infants were born to HCMV-seropositive nontransmitting mothers and 37 to HCMV-seronegative mothers. Controls were matched on sex, race/ethnicity, maternal age, and delivery year. Results Transplacental IgG transfer efficiency was decreased by 23% (95% confidence interval [CI] 10-36%, P = .0079) in cCMV-infected pairs and 75% of this effect (95% CI 28-174%, P = .0085) was mediated by elevated maternal IgG levels (ie, hypergammaglobulinemia) in HCMV-transmitting women. Despite reduced transfer efficiency, IgG levels were similar in cord blood from infants with and without cCMV infection. Conclusions Our results indicate that cCMV infection moderately reduces transplacental IgG transfer efficiency due to maternal hypergammaglobulinemia; however, infants with and without cCMV infection had similar antigen-specific IgG levels, suggesting comparable protection from maternal IgG acquired via transplacental transfer.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据